Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $48.7 million.

  • Haemonetics' Accounts Payables fell 2269.57% to $48.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $48.7 million, marking a year-over-year decrease of 2269.57%. This contributed to the annual value of $67.0 million for FY2025, which is 866.84% down from last year.
  • As of Q4 2025, Haemonetics' Accounts Payables stood at $48.7 million, which was down 2269.57% from $61.7 million recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Accounts Payables peaked at $80.2 million during Q3 2023, and registered a low of $45.0 million during Q4 2021.
  • Over the past 5 years, Haemonetics' median Accounts Payables value was $61.6 million (recorded in 2022), while the average stood at $61.1 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 3672.53% in 2022, then plummeted by 4019.16% in 2025.
  • Quarter analysis of 5 years shows Haemonetics' Accounts Payables stood at $45.0 million in 2021, then soared by 41.81% to $63.8 million in 2022, then dropped by 10.86% to $56.8 million in 2023, then grew by 10.81% to $63.0 million in 2024, then dropped by 22.7% to $48.7 million in 2025.
  • Its Accounts Payables was $48.7 million in Q4 2025, compared to $61.7 million in Q3 2025 and $46.0 million in Q2 2025.